Skip to main content
Figure 4 | Malaria Journal

Figure 4

From: Clinical tolerability of artesunate-amodiaquine versus comparator treatments for uncomplicated falciparum malaria: an individual-patient analysis of eight randomized controlled trials in sub-Saharan Africa

Figure 4

Treatment emergent adverse event (TEAE) forest plots, ASAQ vs. comparator treatments. AOR, adjusted odds ratio for age, log parasitaemia, parasitological reappearance, time, and treatments, randomized by site; CI, confidence interval; AQ, amodiaquine; SP, sulfadoxine-pyrimethamine; DP, dihydroartemisinin-piperaquine; CQ, chloroquine; AS, artesunate; AL, artemether-lumefantrine.

Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us